Infectious Disease Book


Tdap Vaccine

Aka: Tdap Vaccine, Tdap, Tetanus Diptheria Acellular Pertussis Vaccine, Adacel, Boostrix
  1. See Also
    1. Td Vaccine
    2. DTaP Vaccine
    3. Pertussis
    4. Diptheria
    5. Tetanus
  2. Indications
    1. See Tetanus Prophylaxis
    2. Pimary series booster at age 11 years old
    3. Adults 18 to 64 years old for Tetanus booster every 10 years (may substitute for any Td dose)
    4. Pregnant women in third trimester (repeat with each pregnancy)
  3. Preparations
    1. Tdap has reduced antigen concentrations of diptheria and Pertussis than DTaP
      1. Reduces side effects
    2. Products
      1. Boostrix (approved for adolescents ages 10 to 18)
      2. Adacel (approved for ages 11 to 64 years)
  4. Precautions
    1. Pertussis in age <2 months is highest Incidence (160 per 100,000) and high risk (80% hospitalization rate)
      1. Tdap Vaccination is most important for protecting infants from community exposure
      2. (2013) MMWR Morb Mortal Wkly Rep 62(7): 131-5 [PubMed]
  5. Adverse Effects
    1. Injection Site Pain
      1. Severe in 20% of adults
      2. More common with subsequent injections
    2. Flu-Like Symptoms
      1. Occurs in 10% of cases
    3. Low-grade Fever (<38 C, 101 F)
      1. Low grade fever occurs in 13% of patients
    4. Neurologic complications
      1. Seizures are rare (except in Dravet Syndrome)
      2. Transient Brachial Neuritis (rare)
      3. Guillain Barre Syndrome (rare)
  6. Dosing: Schedule
    1. Maintenance with Tdap for teens
      1. Age 11-12 years: Give Tdap instead of Td
      2. Age 13-18 years: Give Tdap if no Td given yet
        1. Consider Tdap instead of Td
    2. Maintenance for adults
      1. Usual interval between Tdap doses
        1. Tdap Vaccine at 11-12 years
        2. As of 2011, ACIP recommends:
          1. Td every 10 years
            1. Single Tdap dose replaces the Td once between 19 to 64 years old
            2. See below for additional Tdap dose indications
          2. Tdap may be given for over age 64 once if close infant contact (off label use)
      2. Indications for shorter interval between Tdap doses
        1. Pregnancy
        2. Regular contact with newborns (e.g. healthcare workers, childcare workers)
        3. Consider early booster during local Pertussis epidemic (e.g. 2012 in U.S.)
      3. Minimal interval between doses (usual interval is 10 years)
        1. Last tetanus Immunization was Tdap
          1. General population: Minimum of 5 years from last Tdap dose
          2. Regular contact with newborns: Minimum of 2 years from last Tdap dose
        2. Last tetanus Immunization was Td
          1. No minimum interval between Td and subsequent Tdap
          2. Administer Tdap now to any adult in contact with newborns
    3. Maintenance for pregnancy
      1. Booster with known prior Immunization
        1. Give Tdap at 27-36 weeks gestation for EACH pregnancy
        2. Allows time for maternal Pertussis antibodies to transfer to the baby (passive immunity)
        3. (2013) Ann Intern Med 158(3):191-9 [PubMed]
      2. Series if Immunization Status Unknown
        1. Dose 1: Tdap at 20 weeks gestation
        2. Dose 2: Td at one month after the first
        3. Dose 3: Td at 6 to 12 months after the first
  7. References
    1. Ackerman (2015) Am Fam Physician 92(6): 460-8 [PubMed]

tdap vaccine (C2054270)

Concepts Immunologic Factor (T129) , Pharmacologic Substance (T121)
English tdap vaccine, tdap vaccine (medication)
Derived from the NIH UMLS (Unified Medical Language System)

You are currently viewing the original '\legacy' version of this website. Internet Explorer 8.0 and older will automatically be redirected to this legacy version.

If you are using a modern web browser, you may instead navigate to the newer desktop version of fpnotebook. Another, mobile version is also available which should function on both newer and older web browsers.

Please Contact Me as you run across problems with any of these versions on the website.

Navigation Tree